Induction of Ankrd1 in dilated cardiomyopathy correlates with the heart failure progression

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Bogomolovas, Julius ^a,b   Brohm, Kathrin ^a   Čelutkiene, Jelena ^b   Balčiunaite, Giedre ^b   Bironaite, Daiva ^c   Bukelskiene, Virginija ^b   Daunoravičus, Dainius ^b   Witt, Christian C ^a   Fielitz, Jens ^d   Grabauskiene, Virginija ^b   Labeit, Siegfried ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b VILNIUS UNIVERSITY   (Lithuania)

^c Center for Innovative Medicine   (Lithuania)

^d MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ANKYRIN; ANKYRIN REPEAT DOMAIN CONTAINING PROTEIN 1; ANKYRIN REPEAT DOMAIN CONTAINING PROTEIN 2; BINDING PROTEIN; BRAIN NATRIURETIC PEPTIDE; CASPASE 3; CONNECTIN; FHL2 PROTEIN; MLP PROTEIN; TCAP PROTEIN; TRIM55 PROTEIN; TRIPARTITE MOTIF PROTEIN 5; TROPONIN T; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; ANKRD1 PROTEIN, HUMAN; LIGAND; MUSCLE PROTEIN; NUCLEAR PROTEIN; REPRESSOR PROTEIN;

ADULT; ARTICLE; CELL STRESS; CELL SURVIVAL; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; DISEASE ASSOCIATION; DISEASE COURSE; ECHOCARDIOGRAPHY; FEMALE; HEART CATHETERIZATION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE BIOPSY; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART VENTRICLE COMPLIANCE; HEART VENTRICLE REMODELING; HUMAN; HUMAN TISSUE; LUNG VASCULAR RESISTANCE; MALE; MOLECULAR PATHOLOGY; NEW YORK HEART ASSOCIATION CLASS; PROTEIN EXPRESSION; PULMONARY ARTERY OCCLUSION PRESSURE; SURVIVAL FACTOR; BIOSYNTHESIS; CARDIAC MUSCLE; GENE EXPRESSION; HEART ATRIUM REMODELING; METABOLISM; MIDDLE AGED; PATHOLOGY;

ADIPONECTIN; ADULT; ATRIAL REMODELING; CARDIOMYOPATHY, DILATED; CONNECTIN; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION; HEART FAILURE; HUMANS; LIGANDS; MALE; MIDDLE AGED; MUSCLE PROTEINS; MYOCARDIUM; NUCLEAR PROTEINS; REPRESSOR PROTEINS;

EID: 84928966508     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/273936     Document Type: Article

References (34)

1. R. Jasaityte, M. Dandel, H. Lehmkuhl, and R. Hetzer, "rediction of short-term outcomes in patients with idiopathic dilated cardiomyopathy referred for transplantation using standard echocardiography and strain imaging, " Transplantation Proceedings, vol. 41, no. 1, pp. 277-280, 2009.
2. P. M. Kang and S. Izumo, "Apoptosis and heart failure: a critical review of the literature, " Circulation Research, vol. 86, no. 11, pp. 1107-1113, 2000.
3. R. Knöll and B. Buyandelger, "Z-disc transcriptional coupling, sarcomeroptosis and mechanoptosis, " Cell Biochemistry and Biophysics, vol. 66, no. 1, pp. 65-71, 2013.
4. M. K. Miller, M.-L. Bang, C. C. Witt et al., "Themuscle ankyrin repeat proteins: CARP, ankrd2/Arpp and DARP as a family of titin filament-based stress response molecules, " Journal of Molecular Biology, vol. 333, no. 5, pp. 951-964, 2003.
5. Y. Aihara, M. Kurabayashi, Y. Saito et al., "Cardiac ankyrin repeat protein is a novel marker of cardiac hypertrophy: role of M-CAT element within the promoter, " Hypertension, vol. 36, no. 1, pp. 48-53, 2000.
6. S. F. Nagueh, G. Shah, Y. Wu et al., "Altered titin expression, myocardial stiffness, and left ventricular function in patients with dilated cardiomyopathy, " Circulation, vol. 110, no. 2, pp. 155-162, 2004.
7. Y.-J. Wei, C.-J. Cui, Y.-X. Huang, X.-L. Zhang, H. Zhang, and S.-S. Hu, "Upregulated expression of cardiac ankyrin repeat protein in human failing hearts due to arrhythmogenic right ventricular cardiomyopathy, " European Journal of Heart Failure, vol. 11, no. 6, pp. 559-566, 2009.
8. M. Moulik, M. Vatta, S. H. Witt et al., "ANKRD1, the gene encoding cardiac ankyrin repeat protein, is a novel dilated cardiomyopathy gene, " Journal of the American College of Cardiology, vol. 54, no. 4, pp. 325-333, 2009.
9. T. Arimura, J. M. Bos, A. Sato et al., "Cardiac ankyrin repeat protein gene (ANKRD1) mutations in hypertrophic cardiomyopathy, " Journal of the American College of Cardiology, vol. 54, no. 4, pp. 334-342, 2009.
10. M.-J. Lee, Y.-K. Kwak, K.-R. You, B.-H. Lee, and D.-G. Kim, "Involvement of GADD153 and cardiac ankyrin repeat protein in cardiac ischemia-reperfusion injury, " Experimental and Molecular Medicine, vol. 41, no. 4, pp. 243-252, 2009.
11. X.-J. Han, J.-K. Chae, M.-J. Lee, K.-R. You, B.-H. Lee, and D.-G. Kim, "Involvement of GADD153 and cardiac ankyrin repeat protein in hypoxia-induced apoptosis ofH9c2 cells, "TheJournal of Biological Chemistry, vol. 280, no. 24, pp. 23122-23129, 2005.
12. P. J. Lee, D. Rudenko, M. A. Kuliszewski et al., "Survivin gene therapy attenuates left ventricular systolic dysfunction in doxorubicin cardiomyopathy by reducing apoptosis and fibrosis, " Cardiovascular Research, vol. 101, no. 3, pp. 423-433, 2014.
13. T. Nakamura, Y. Ueda, Y. Juan, S. Katsuda, H. Takahashi, and E. Koh, "Fas-mediated apoptosis in Adriamycin-induced cardiomyopathy in rats: in vivo study, " Circulation, vol. 102, no. 5, pp. 572-578, 2000.
14. B. Chen, L. Zhong, S. F. Roush et al., "Disruption of a GATA4/Ankrd1 signaling axis in cardiomyocytes leads to sarcomere disarray: implications for anthracycline cardiomyopathy, " PLoS ONE, vol. 7, no. 4, Article ID e35743, 2012.
15. J. S. Yuan, A. Reed, F. Chen, and C. N. Stewart Jr., "Statistical analysis of real-time PCR data, " BMC Bioinformatics, vol. 7, article 85, 2006.
16. N. L. Greenberg, M. S. Firstenberg, P. L. Castro et al., "Dopplerderived myocardial systolic strain rate is a strong index of left ventricular contractility, " Circulation, vol. 105, no. 1, pp. 99-105, 2002.
17. W. C. Little, M. Ohno, D. W. Kitzman, J. D. Thomas, and C.-P. Cheng, "Determination of left ventricular chamber stiffness from the time for deceleration of early left ventricular filling, " Circulation, vol. 92, no. 7, pp. 1933-1939, 1995.
18. D. Wencker, M. Chandra, K. Nguyen et al., "A mechanistic role for cardiac myocyte apoptosis in heart failure, " The Journal of Clinical Investigation, vol. 111, no. 10, pp. 1497-1504, 2003.
19. K.-L. Laugwitz, A. Schömig, M. Ungerer et al., "Blocking caspase-activated apoptosis improves contractility in failing myocardium, " Human Gene Therapy, vol. 12, no. 17, pp. 2051-2063, 2001.
20. S. Cheng, M. G. Larson, E. L. McCabe et al., "Age-and sexbased reference limits and clinical correlates of myocardial strain and synchrony: the framingham heart study, " Circulation: Cardiovascular Imaging, vol. 6, no. 5, pp. 692-699, 2013.
21. Z. N. Oltvai, C. L. Milliman, and S. J. Korsmeyer, "Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death, " Cell, vol. 74, no. 4, pp. 609-619, 1993.
22. G. M. Cohen, "Caspases: the executioners of apoptosis, " The Biochemical Journal, vol. 326, no. 1, pp. 1-16, 1997.
23. O. Akyürek, N. Akyürek, T. Sayin et al., "Association between the severity of heart failure and the susceptibility ofmyocytes to apoptosis in patients with idiopathic dilated cardiomyopathy, " International Journal of Cardiology, vol. 80, no. 1, pp. 29-36, 2001.
24. W. Kosmala, R. Plaksej, J. M. Strotmann et al., "Progression of left ventricular functional abnormalities in hypertensive patients with heart failure: an ultrasonic two-dimensional speckle tracking study, " Journal of the American Society of Echocardiography, vol. 21, no. 12, pp. 1309-1317, 2008.
25. C. S. Rihal, R. A. Nishimura, L. K. Hatle, K. R. Bailey, and A. J. Tajik, "Systolic and diastolic dysfunction in patients with clinical diagnosis of dilated cardiomyopathy: relation to symptoms and prognosis, " Circulation, vol. 90, no. 6, pp. 2772-2779, 1994.
26. W. Ibe, A. Saraste, S. Lindemann et al., "Cardiomyocyte apoptosis is related to left ventricular dysfunction and remodelling in dilated cardiomyopathy, but is not affected by growth hormone treatment, " European Journal of Heart Failure, vol. 9, no. 2, pp. 160-167, 2007.
27. N. Latif, M. A. Khan, E. Birks et al., "Upregulation of the Bcl-2 family of proteins in end stage heart failure, " Journal of the American College of Cardiology, vol. 35, no. 7, pp. 1769-1777, 2000.
28. C. Kistorp, J. Faber, S. Galatius et al., "Plasma adiponectin, body mass index, andmortality in patients with chronic heart failure, " Circulation, vol. 112, no. 12, pp. 1756-1762, 2005.
29. Y. Zhang, X.-L. Wang, J. Zhao et al., "Adiponectin inhibits oxidative/nitrative stress during myocardial ischemia and reperfusion via PKA signaling, " American Journal of Physiology-Endocrinology and Metabolism, vol. 305, no. 12, pp. E1436-E1443, 2013.
30. C. A. Beltrami, N. Finato, M. Rocco et al., "Structural basis of end-stage failure in ischemic cardiomyopathy in humans, " Circulation, vol. 89, no. 1, pp. 151-163, 1994.
31. W. Cheng, B. Li, J. Kajstura et al., "Stretch-induced programmed myocyte cell death, "The Journal of Clinical Investigation, vol. 96, no. 5, pp. 2247-2259, 1995.
32. D. S. Herman, L. Lam, M. R. G. Taylor et al., "Truncations of titin causing dilated cardiomyopathy, "The New England Journal of Medicine, vol. 366, no. 7, pp. 619-628, 2012.
33. M. Moulik, M. Vatta, S. H. Witt et al., "ANKRD1, the gene encoding cardiac ankyrin repeat protein, is a novel dilated cardiomyopathy gene, " Journal of the American College of Cardiology, vol. 54, no. 4, pp. 325-333, 2009.
34. L. Duboscq-Bidot, P. Charron, V. Ruppert et al., "Mutations in the ANKRD1 gene encoding CARP are responsible for human dilated cardiomyopathy, " EuropeanHeart Journal, vol. 30, no. 17, pp. 2128-2136, 2009.